Victory Capital Management Inc. Has $20.33 Million Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Victory Capital Management Inc. lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 778,553 shares of the pharmacy operator’s stock after selling 130,428 shares during the period. Victory Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $20,328,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Sivik Global Healthcare LLC purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth approximately $2,350,000. Parthenon LLC raised its holdings in shares of Walgreens Boots Alliance by 2.7% during the fourth quarter. Parthenon LLC now owns 58,785 shares of the pharmacy operator’s stock worth $1,535,000 after acquiring an additional 1,542 shares in the last quarter. Savant Capital LLC grew its stake in Walgreens Boots Alliance by 49.2% in the fourth quarter. Savant Capital LLC now owns 50,733 shares of the pharmacy operator’s stock valued at $1,325,000 after purchasing an additional 16,734 shares in the last quarter. Kestra Private Wealth Services LLC grew its stake in Walgreens Boots Alliance by 4.3% in the fourth quarter. Kestra Private Wealth Services LLC now owns 25,017 shares of the pharmacy operator’s stock valued at $653,000 after purchasing an additional 1,024 shares in the last quarter. Finally, Altrius Capital Management Inc increased its position in Walgreens Boots Alliance by 1.5% in the 4th quarter. Altrius Capital Management Inc now owns 153,740 shares of the pharmacy operator’s stock worth $4,014,000 after purchasing an additional 2,321 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $17.25 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The firm’s 50-day moving average is $19.35 and its 200-day moving average is $21.50. Walgreens Boots Alliance, Inc. has a 52-week low of $17.13 and a 52-week high of $32.89. The company has a market cap of $14.88 billion, a price-to-earnings ratio of -2.46, a PEG ratio of 1.10 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the company earned $1.16 EPS. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.80%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is -14.29%.

Insider Transactions at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. In other news, CFO Manmohan Mahajan acquired 6,000 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Inderpal S. Bhandari bought 3,000 shares of the business’s stock in a transaction dated Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on WBA shares. Deutsche Bank Aktiengesellschaft reduced their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a report on Wednesday, April 3rd. Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. HSBC restated a “reduce” rating and set a $20.00 price target (down previously from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a report on Monday, April 1st. Finally, TD Cowen cut their price objective on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.